目的 了解南京市第二醫(yī)院2012-2016年甘草酸類抗肝炎藥物的門診使用情況，分析該類藥物的使用特點(diǎn)和趨勢，為臨床合理用藥和科學(xué)管理提供參考。方法 收集南京市第二醫(yī)院2012-2016年甘草酸類藥物的門診使用資料，對消耗量、銷售金額、用藥頻度（DDDs）、日均費(fèi)用（DDC）進(jìn)行分析。結(jié)果 2012-2016年，從消耗量和銷售金額來看，甘草酸二銨所占構(gòu)成比最大，且逐年遞增，在2016年分別占到74.70%、69.52%；從DDDs排序來看，復(fù)方甘草酸苷制劑和甘草酸二銨分別排在前兩位，其DDC分別排在第5、3位，DDC最高的是異甘草酸鎂注射液。結(jié)論 南京市第二醫(yī)院門診治療肝炎以第3代的甘草酸類藥物甘草酸二銨制劑為主，這與其低廉的價(jià)格和適宜的用藥頻度是一致的。

Objective To investigate the utilization condition of glycyrrhizic acid anti-hepatitis drugs in outpatient department of the Second Hospital of Nanjing from 2012 to 2016, and to analyze the characteristics and tendency so as to provide references for the rational use and scientific management of glycyrrhizic acid drugs. Methods The consumption data of glycyrrhizic acid drugs in the Second Hospital of Nanjing from 2012 to 2016 were collected for analysis of consumption sum, sales amount, frequency of drug use (DDDs), and average daily cost (DDC), etc. Results From 2012 to 2016, consumption sum and sales amount of diammonium glycyrrhizinate accounted for the largest proportion, and increased year by year, accounted for 74.70% and 69.52% in 2016. From the point of view of DDDs sequencing, compound glycyrrhizic acid preparation and diammonium glycyrrhizinate were ranked in the top two, respectively, and DDC were ranked in the fifth and the third. DDC of Magnesium Isobutyrate Injection ranked the highest. Conclusion The third generation of glycyrrhizic acid preparation diammonium glycyrrhizinate is mainly used in outpatient department of the Second Hospital of Nanjing, which is consistent to its low price and appropriate frequency of medication.